GlassScriptPhysician profile
Zaid Alnoah
NPI 1053570432
$2,830.27
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $297 · 2021: $573 · 2022: $558 · 2023: $657 · 2024: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,008.26 | 2020-2024 | Linzess, Viberzi, Rinvoq |
| Janssen Biotech, INC. | $428.93 | 2019-2024 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $309.00 | 2021-2023 | Trulance, Relistor |
| Celgene Corporation | $252.63 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $114.97 | 2019-2024 | Entyvio |
| Gilead Sciences, INC. | $112.80 | 2020-2023 | |
| Madrigal Pharmaceuticals | $81.91 | 2024 | Resmetirom |
| Ardelyx, INC. | $80.81 | 2023-2024 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $68.68 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $64.35 | 2021-2023 | |
| Braintree Laboratories, INC. | $61.75 | 2020-2022 | |
| Pfizer INC. | $58.02 | 2019-2024 | |
| Cook Medical LLC | $29.33 | 2023 | Hemospray |
| Olympus America INC. | $29.02 | 2023-2024 | Endoclot Phs, Endoclot Sis |
| Allergan, INC. | $28.09 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $23.02 | 2023 | Ocaliva |
| Merck Sharp & Dohme LLC | $21.54 | 2023 | Dificid |
| Novo Nordisk INC | $15.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.19 | 2022 | |
| Lilly USA, LLC | $12.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaid Alnoah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.